• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and Japan Tumor Markers Immunoassay Market Size, Status and Forecast 2020-2026

report cover
  • 29 October 2020
  • Pharmaceuticals
  • 131 Pages
  • Report Code: 24LS-21684
  • Formate :   
Download FREE Report Sample Download PDF File

Tumor Markers Immunoassay -MARKET ADVISORY SERVICES

Global Tumor Markers Immunoassay Scope and Market Size
Tumor Markers Immunoassay market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Markers Immunoassay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
ProGRP
PSA (complexed, free, total))
SCC (squamous cell carcinoma antigen)
Serum HER-2/neu
Thyroglobulin
CA 72-4
Others

Market segment by Application, split into
Liver Cancer
Breast Cancer
Others

Based on regional and country-level analysis, the Tumor Markers Immunoassay market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Tumor Markers Immunoassay market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Clarity Diagnostics, LLC
CTK Biotech, Inc
DIALAB GmbH
Ortho Clinical Diagnostics
Polymedco, Inc
DIAsource ImmunoAssays SA
DRG International, Inc
Fujirebio US, Inc
Bioscience (Tianjin) Diagnostic Technology Co., Ltd
Boson Biotech Co., Ltd
Qualigen, Inc
Randox Laboratories, Ltd
Roche Diagnostic Corporation
Siemens Healthineers
Syntron Bioresearch, Inc
Teco Diagnostics
Thermo Fisher Scientific, Inc
Tosoh Bioscience, Inc
Diametra
DiaSorin S.p.A
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Markers Immunoassay Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 ProGRP
1.2.3 PSA (complexed, free, total))
1.2.4 SCC (squamous cell carcinoma antigen)
1.2.5 Serum HER-2/neu
1.2.6 Thyroglobulin
1.2.7 CA 72-4
1.2.8 Others
1.3 Market by Application
1.3.1 Global Tumor Markers Immunoassay Market Share by Application: 2020 VS 2026
1.3.2 Liver Cancer
1.3.3 Breast Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tumor Markers Immunoassay Market Perspective (2015-2026)
2.2 Global Tumor Markers Immunoassay Growth Trends by Regions
2.2.1 Tumor Markers Immunoassay Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tumor Markers Immunoassay Historic Market Share by Regions (2015-2020)
2.2.3 Tumor Markers Immunoassay Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tumor Markers Immunoassay Players by Market Size
3.1.1 Global Top Tumor Markers Immunoassay Players by Revenue (2015-2020)
3.1.2 Global Tumor Markers Immunoassay Revenue Market Share by Players (2015-2020)
3.2 Global Tumor Markers Immunoassay Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tumor Markers Immunoassay Revenue
3.4 Global Tumor Markers Immunoassay Market Concentration Ratio
3.4.1 Global Tumor Markers Immunoassay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Markers Immunoassay Revenue in 2019
3.5 Key Players Tumor Markers Immunoassay Area Served
3.6 Key Players Tumor Markers Immunoassay Product Solution and Service
3.7 Date of Enter into Tumor Markers Immunoassay Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Markers Immunoassay Breakdown Data by Type (2015-2026)
4.1 Global Tumor Markers Immunoassay Historic Market Size by Type (2015-2020)
4.2 Global Tumor Markers Immunoassay Forecasted Market Size by Type (2021-2026)

5 Tumor Markers Immunoassay Breakdown Data by Application (2015-2026)
5.1 Global Tumor Markers Immunoassay Historic Market Size by Application (2015-2020)
5.2 Global Tumor Markers Immunoassay Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Tumor Markers Immunoassay Market Size (2015-2026)
6.2 North America Tumor Markers Immunoassay Market Size by Type (2015-2020)
6.3 North America Tumor Markers Immunoassay Market Size by Application (2015-2020)
6.4 North America Tumor Markers Immunoassay Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Tumor Markers Immunoassay Market Size (2015-2026)
7.2 Europe Tumor Markers Immunoassay Market Size by Type (2015-2020)
7.3 Europe Tumor Markers Immunoassay Market Size by Application (2015-2020)
7.4 Europe Tumor Markers Immunoassay Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Tumor Markers Immunoassay Market Size (2015-2026)
8.2 China Tumor Markers Immunoassay Market Size by Type (2015-2020)
8.3 China Tumor Markers Immunoassay Market Size by Application (2015-2020)
8.4 China Tumor Markers Immunoassay Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Tumor Markers Immunoassay Market Size (2015-2026)
9.2 Japan Tumor Markers Immunoassay Market Size by Type (2015-2020)
9.3 Japan Tumor Markers Immunoassay Market Size by Application (2015-2020)
9.4 Japan Tumor Markers Immunoassay Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Tumor Markers Immunoassay Market Size (2015-2026)
10.2 Southeast Asia Tumor Markers Immunoassay Market Size by Type (2015-2020)
10.3 Southeast Asia Tumor Markers Immunoassay Market Size by Application (2015-2020)
10.4 Southeast Asia Tumor Markers Immunoassay Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 Clarity Diagnostics, LLC
11.1.1 Clarity Diagnostics, LLC Company Details
11.1.2 Clarity Diagnostics, LLC Business Overview
11.1.3 Clarity Diagnostics, LLC Tumor Markers Immunoassay Introduction
11.1.4 Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2015-2020))
11.1.5 Clarity Diagnostics, LLC Recent Development
11.2 CTK Biotech, Inc
11.2.1 CTK Biotech, Inc Company Details
11.2.2 CTK Biotech, Inc Business Overview
11.2.3 CTK Biotech, Inc Tumor Markers Immunoassay Introduction
11.2.4 CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
11.2.5 CTK Biotech, Inc Recent Development
11.3 DIALAB GmbH
11.3.1 DIALAB GmbH Company Details
11.3.2 DIALAB GmbH Business Overview
11.3.3 DIALAB GmbH Tumor Markers Immunoassay Introduction
11.3.4 DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2015-2020)
11.3.5 DIALAB GmbH Recent Development
11.4 Ortho Clinical Diagnostics
11.4.1 Ortho Clinical Diagnostics Company Details
11.4.2 Ortho Clinical Diagnostics Business Overview
11.4.3 Ortho Clinical Diagnostics Tumor Markers Immunoassay Introduction
11.4.4 Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2015-2020)
11.4.5 Ortho Clinical Diagnostics Recent Development
11.5 Polymedco, Inc
11.5.1 Polymedco, Inc Company Details
11.5.2 Polymedco, Inc Business Overview
11.5.3 Polymedco, Inc Tumor Markers Immunoassay Introduction
11.5.4 Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
11.5.5 Polymedco, Inc Recent Development
11.6 DIAsource ImmunoAssays SA
11.6.1 DIAsource ImmunoAssays SA Company Details
11.6.2 DIAsource ImmunoAssays SA Business Overview
11.6.3 DIAsource ImmunoAssays SA Tumor Markers Immunoassay Introduction
11.6.4 DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2015-2020)
11.6.5 DIAsource ImmunoAssays SA Recent Development
11.7 DRG International, Inc
11.7.1 DRG International, Inc Company Details
11.7.2 DRG International, Inc Business Overview
11.7.3 DRG International, Inc Tumor Markers Immunoassay Introduction
11.7.4 DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
11.7.5 DRG International, Inc Recent Development
11.8 Fujirebio US, Inc
11.8.1 Fujirebio US, Inc Company Details
11.8.2 Fujirebio US, Inc Business Overview
11.8.3 Fujirebio US, Inc Tumor Markers Immunoassay Introduction
11.8.4 Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
11.8.5 Fujirebio US, Inc Recent Development
11.9 Bioscience (Tianjin) Diagnostic Technology Co., Ltd
11.9.1 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Details
11.9.2 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Business Overview
11.9.3 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Tumor Markers Immunoassay Introduction
11.9.4 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020)
11.9.5 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Development
11.10 Boson Biotech Co., Ltd
11.10.1 Boson Biotech Co., Ltd Company Details
11.10.2 Boson Biotech Co., Ltd Business Overview
11.10.3 Boson Biotech Co., Ltd Tumor Markers Immunoassay Introduction
11.10.4 Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020)
11.10.5 Boson Biotech Co., Ltd Recent Development
11.11 Qualigen, Inc
10.11.1 Qualigen, Inc Company Details
10.11.2 Qualigen, Inc Business Overview
10.11.3 Qualigen, Inc Tumor Markers Immunoassay Introduction
10.11.4 Qualigen, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.11.5 Qualigen, Inc Recent Development
11.12 Randox Laboratories, Ltd
10.12.1 Randox Laboratories, Ltd Company Details
10.12.2 Randox Laboratories, Ltd Business Overview
10.12.3 Randox Laboratories, Ltd Tumor Markers Immunoassay Introduction
10.12.4 Randox Laboratories, Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.12.5 Randox Laboratories, Ltd Recent Development
11.13 Roche Diagnostic Corporation
10.13.1 Roche Diagnostic Corporation Company Details
10.13.2 Roche Diagnostic Corporation Business Overview
10.13.3 Roche Diagnostic Corporation Tumor Markers Immunoassay Introduction
10.13.4 Roche Diagnostic Corporation Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.13.5 Roche Diagnostic Corporation Recent Development
11.14 Siemens Healthineers
10.14.1 Siemens Healthineers Company Details
10.14.2 Siemens Healthineers Business Overview
10.14.3 Siemens Healthineers Tumor Markers Immunoassay Introduction
10.14.4 Siemens Healthineers Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.14.5 Siemens Healthineers Recent Development
11.15 Syntron Bioresearch, Inc
10.15.1 Syntron Bioresearch, Inc Company Details
10.15.2 Syntron Bioresearch, Inc Business Overview
10.15.3 Syntron Bioresearch, Inc Tumor Markers Immunoassay Introduction
10.15.4 Syntron Bioresearch, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.15.5 Syntron Bioresearch, Inc Recent Development
11.16 Teco Diagnostics
10.16.1 Teco Diagnostics Company Details
10.16.2 Teco Diagnostics Business Overview
10.16.3 Teco Diagnostics Tumor Markers Immunoassay Introduction
10.16.4 Teco Diagnostics Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.16.5 Teco Diagnostics Recent Development
11.17 Thermo Fisher Scientific, Inc
10.17.1 Thermo Fisher Scientific, Inc Company Details
10.17.2 Thermo Fisher Scientific, Inc Business Overview
10.17.3 Thermo Fisher Scientific, Inc Tumor Markers Immunoassay Introduction
10.17.4 Thermo Fisher Scientific, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.17.5 Thermo Fisher Scientific, Inc Recent Development
11.18 Tosoh Bioscience, Inc
10.18.1 Tosoh Bioscience, Inc Company Details
10.18.2 Tosoh Bioscience, Inc Business Overview
10.18.3 Tosoh Bioscience, Inc Tumor Markers Immunoassay Introduction
10.18.4 Tosoh Bioscience, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.18.5 Tosoh Bioscience, Inc Recent Development
11.19 Diametra
10.19.1 Diametra Company Details
10.19.2 Diametra Business Overview
10.19.3 Diametra Tumor Markers Immunoassay Introduction
10.19.4 Diametra Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.19.5 Diametra Recent Development
11.20 DiaSorin S.p.A
10.20.1 DiaSorin S.p.A Company Details
10.20.2 DiaSorin S.p.A Business Overview
10.20.3 DiaSorin S.p.A Tumor Markers Immunoassay Introduction
10.20.4 DiaSorin S.p.A Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.20.5 DiaSorin S.p.A Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables

Table 1. Global Tumor Markers Immunoassay Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 3. Key Players of ProGRP

Table 4. Key Players of PSA (complexed, free, total))

Table 5. Key Players of SCC (squamous cell carcinoma antigen)

Table 6. Key Players of Serum HER-2/neu

Table 7. Key Players of Thyroglobulin

Table 8. Key Players of CA 72-4

Table 9. Key Players of Others

Table 10. Global Tumor Markers Immunoassay Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 11. Global Tumor Markers Immunoassay Market Size by Regions (US$ Million): 2020 VS 2026

Table 12. Global Tumor Markers Immunoassay Market Size by Regions (2015-2020) (US$ Million)

Table 13. Global Tumor Markers Immunoassay Market Share by Regions (2015-2020)

Table 14. Global Tumor Markers Immunoassay Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 15. Global Tumor Markers Immunoassay Market Share by Regions (2021-2026)

Table 16. Tumor Markers Immunoassay Market Market Trends

Table 17. Tumor Markers Immunoassay Market Drivers

Table 18. Tumor Markers Immunoassay Market Challenges

Table 19. Tumor Markers Immunoassay Market Restraints

Table 20. Global Tumor Markers Immunoassay Revenue by Players (2015-2020) (US$ Million)

Table 21. Global Tumor Markers Immunoassay Market Share by Players (2015-2020)

Table 22. Global Top Tumor Markers Immunoassay Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Markers Immunoassay as of 2019)

Table 23. Global Tumor Markers Immunoassay by Players Market Concentration Ratio (CR5 and HHI)

Table 24. Key Players Headquarters and Area Served

Table 25. Key Players Tumor Markers Immunoassay Product Solution and Service

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Tumor Markers Immunoassay Market Size by Type (2015-2020) (US$ Million)

Table 28. Global Tumor Markers Immunoassay Market Size Share by Type (2015-2020)

Table 29. Global Tumor Markers Immunoassay Revenue Market Share by Type (2021-2026)

Table 30. Global Tumor Markers Immunoassay Market Size Share by Application (2015-2020)

Table 31. Global Tumor Markers Immunoassay Market Size by Application (2015-2020) (US$ Million)

Table 32. Global Tumor Markers Immunoassay Market Size Share by Application (2021-2026)

Table 33. North America Tumor Markers Immunoassay Market Size by Type (2015-2020) (US$ Million)

Table 34. North America Tumor Markers Immunoassay Market Share by Type (2015-2020)

Table 35. North America Tumor Markers Immunoassay Market Size by Application (2015-2020) (US$ Million)

Table 36. North America Tumor Markers Immunoassay Market Share by Application (2015-2020)

Table 37. North America Tumor Markers Immunoassay Market Size by Country (US$ Million) (2015-2020)

Table 38. North America Tumor Markers Immunoassay Market Share by Country (2015-2020)

Table 39. Europe Tumor Markers Immunoassay Market Size by Type (2015-2020) (US$ Million)

Table 40. Europe Tumor Markers Immunoassay Market Share by Type (2015-2020)

Table 41. Europe Tumor Markers Immunoassay Market Size by Application (2015-2020) (US$ Million)

Table 42. Europe Tumor Markers Immunoassay Market Share by Application (2015-2020)

Table 43. Europe Tumor Markers Immunoassay Market Size by Country (US$ Million) (2015-2020)

Table 44. Europe Tumor Markers Immunoassay Market Share by Country (2015-2020)

Table 45. China Tumor Markers Immunoassay Market Size by Type (2015-2020) (US$ Million)

Table 46. China Tumor Markers Immunoassay Market Share by Type (2015-2020)

Table 47. China Tumor Markers Immunoassay Market Size by Application (2015-2020) (US$ Million)

Table 48. China Tumor Markers Immunoassay Market Share by Application (2015-2020)

Table 49. China Tumor Markers Immunoassay Market Size by Region (US$ Million) (2015-2020)

Table 50. China Tumor Markers Immunoassay Market Share by Region (2015-2020)

Table 51. Japan Tumor Markers Immunoassay Market Size by Type (2015-2020) (US$ Million)

Table 52. Japan Tumor Markers Immunoassay Market Share by Type (2015-2020)

Table 53. Japan Tumor Markers Immunoassay Market Size by Application (2015-2020) (US$ Million)

Table 54. Japan Tumor Markers Immunoassay Market Share by Application (2015-2020)

Table 55. Japan Tumor Markers Immunoassay Market Size by Country (US$ Million) (2015-2020)

Table 56. Japan Tumor Markers Immunoassay Market Share by Country (2015-2020)

Table 57. Southeast Asia Tumor Markers Immunoassay Market Size by Type (2015-2020) (US$ Million)

Table 58. Southeast Asia Tumor Markers Immunoassay Market Share by Type (2015-2020)

Table 59. Southeast Asia Tumor Markers Immunoassay Market Size by Application (2015-2020) (US$ Million)

Table 60. Southeast Asia Tumor Markers Immunoassay Market Share by Application (2015-2020)

Table 61. Southeast Asia Tumor Markers Immunoassay Market Size by Country (US$ Million) (2015-2020)

Table 62. Southeast Asia Tumor Markers Immunoassay Market Share by Country (2015-2020)

Table 63. Clarity Diagnostics, LLC Company Details

Table 64. Clarity Diagnostics, LLC Business Overview

Table 65. Clarity Diagnostics, LLC Product

Table 66. Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 67. Clarity Diagnostics, LLC Recent Development

Table 68. CTK Biotech, Inc Company Details

Table 69. CTK Biotech, Inc Business Overview

Table 70. CTK Biotech, Inc Product

Table 71. CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 72. CTK Biotech, Inc Recent Development

Table 73. DIALAB GmbH Company Details

Table 74. DIALAB GmbH Business Overview

Table 75. DIALAB GmbH Product

Table 76. DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 77. DIALAB GmbH Recent Development

Table 78. Ortho Clinical Diagnostics Company Details

Table 79. Ortho Clinical Diagnostics Business Overview

Table 80. Ortho Clinical Diagnostics Product

Table 81. Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 82. Ortho Clinical Diagnostics Recent Development

Table 83. Polymedco, Inc Company Details

Table 84. Polymedco, Inc Business Overview

Table 85. Polymedco, Inc Product

Table 86. Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 87. Polymedco, Inc Recent Development

Table 88. DIAsource ImmunoAssays SA Company Details

Table 89. DIAsource ImmunoAssays SA Business Overview

Table 90. DIAsource ImmunoAssays SA Product

Table 91. DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 92. DIAsource ImmunoAssays SA Recent Development

Table 93. DRG International, Inc Company Details

Table 94. DRG International, Inc Business Overview

Table 95. DRG International, Inc Product

Table 96. DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 97. DRG International, Inc Recent Development

Table 98. Fujirebio US, Inc Business Overview

Table 99. Fujirebio US, Inc Product

Table 100. Fujirebio US, Inc Company Details

Table 101. Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 102. Fujirebio US, Inc Recent Development

Table 103. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Details

Table 104. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Business Overview

Table 105. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Product

Table 106. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 107. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Development

Table 108. Boson Biotech Co., Ltd Company Details

Table 109. Boson Biotech Co., Ltd Business Overview

Table 110. Boson Biotech Co., Ltd Product

Table 111. Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 112. Boson Biotech Co., Ltd Recent Development

Table 113. Qualigen, Inc Company Details

Table 114. Qualigen, Inc Business Overview

Table 115. Qualigen, Inc Product

Table 116. Qualigen, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 117. Qualigen, Inc Recent Development

Table 118. Randox Laboratories, Ltd Company Details

Table 119. Randox Laboratories, Ltd Business Overview

Table 120. Randox Laboratories, Ltd Product

Table 121. Randox Laboratories, Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 122. Randox Laboratories, Ltd Recent Development

Table 123. Roche Diagnostic Corporation Company Details

Table 124. Roche Diagnostic Corporation Business Overview

Table 125. Roche Diagnostic Corporation Product

Table 126. Roche Diagnostic Corporation Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 127. Roche Diagnostic Corporation Recent Development

Table 128. Siemens Healthineers Company Details

Table 129. Siemens Healthineers Business Overview

Table 130. Siemens Healthineers Product

Table 131. Siemens Healthineers Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 132. Siemens Healthineers Recent Development

Table 133. Syntron Bioresearch, Inc Company Details

Table 134. Syntron Bioresearch, Inc Business Overview

Table 135. Syntron Bioresearch, Inc Product

Table 136. Syntron Bioresearch, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 137. Syntron Bioresearch, Inc Recent Development

Table 138. Teco Diagnostics Company Details

Table 139. Teco Diagnostics Business Overview

Table 140. Teco Diagnostics Product

Table 141. Teco Diagnostics Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 142. Teco Diagnostics Recent Development

Table 143. Thermo Fisher Scientific, Inc Company Details

Table 144. Thermo Fisher Scientific, Inc Business Overview

Table 145. Thermo Fisher Scientific, Inc Product

Table 146. Thermo Fisher Scientific, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 147. Thermo Fisher Scientific, Inc Recent Development

Table 148. Tosoh Bioscience, Inc Company Details

Table 149. Tosoh Bioscience, Inc Business Overview

Table 150. Tosoh Bioscience, Inc Product

Table 151. Tosoh Bioscience, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 152. Tosoh Bioscience, Inc Recent Development

Table 153. Diametra Company Details

Table 154. Diametra Business Overview

Table 155. Diametra Product

Table 156. Diametra Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 157. Diametra Recent Development

Table 158. DiaSorin S.p.A Company Details

Table 159. DiaSorin S.p.A Business Overview

Table 160. DiaSorin S.p.A Product

Table 161. DiaSorin S.p.A Revenue in Tumor Markers Immunoassay Business (2015-2020) (US$ Million)

Table 162. DiaSorin S.p.A Recent Development

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tumor Markers Immunoassay Market Share by Type: 2020 VS 2026

Figure 2. ProGRP Features

Figure 3. PSA (complexed, free, total)) Features

Figure 4. SCC (squamous cell carcinoma antigen) Features

Figure 5. Serum HER-2/neu Features

Figure 6. Thyroglobulin Features

Figure 7. CA 72-4 Features

Figure 8. Others Features

Figure 9. Global Tumor Markers Immunoassay Market Share by Application: 2020 VS 2026

Figure 10. Liver Cancer Case Studies

Figure 11. Breast Cancer Case Studies

Figure 12. Others Case Studies

Figure 13. Tumor Markers Immunoassay Report Years Considered

Figure 14. Global Tumor Markers Immunoassay Market Size (US$ Million), YoY Growth 2015-2026

Figure 15. Global Tumor Markers Immunoassay Market Share by Regions: 2020 VS 2026

Figure 16. Global Tumor Markers Immunoassay Market Share by Regions (2021-2026)

Figure 17. Global Tumor Markers Immunoassay Market Share by Players in 2019

Figure 18. Global Top Tumor Markers Immunoassay Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Markers Immunoassay as of 2019

Figure 19. The Top 10 and 5 Players Market Share by Tumor Markers Immunoassay Revenue in 2019

Figure 20. North America Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 21. United States Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 22. Canada Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 23. Europe Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 24. Germany Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 25. France Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 26. U.K. Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 27. Italy Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 28. Russia Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 29. Nordic Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 30. Rest of Europe Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 31. Asia-Pacific Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 32. China Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 33. Japan Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 34. South Korea Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 35. Southeast Asia Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 36. India Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 37. Australia Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 38. Rest of Asia-Pacific Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 39. Latin America Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 40. Mexico Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 41. Brazil Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 42. Middle East & Africa Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 43. Turkey Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 44. Saudi Arabia Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 45. UAE Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 46. Rest of Middle East & Africa Tumor Markers Immunoassay Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 47. Clarity Diagnostics, LLC Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 48. CTK Biotech, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 49. DIALAB GmbH Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 50. Ortho Clinical Diagnostics Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 51. Polymedco, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 52. DIAsource ImmunoAssays SA Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 53. DRG International, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 54. Fujirebio US, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 55. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 56. Boson Biotech Co., Ltd Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 57. Qualigen, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 58. Randox Laboratories, Ltd Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 59. Roche Diagnostic Corporation Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 60. Siemens Healthineers Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 61. Syntron Bioresearch, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 62. Teco Diagnostics Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 63. Thermo Fisher Scientific, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 64. Tosoh Bioscience, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 65. Diametra Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 66. DiaSorin S.p.A Revenue Growth Rate in Tumor Markers Immunoassay Business (2015-2020)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

Clarity Diagnostics, LLC

CTK Biotech, Inc

DIALAB GmbH

Ortho Clinical Diagnostics

Polymedco, Inc

DIAsource ImmunoAssays SA

DRG International, Inc

Fujirebio US, Inc

Bioscience (Tianjin) Diagnostic Technology Co., Ltd

Boson Biotech Co., Ltd

Qualigen, Inc

Randox Laboratories, Ltd

Roche Diagnostic Corporation

Siemens Healthineers

Syntron Bioresearch, Inc

Teco Diagnostics

Thermo Fisher Scientific, Inc

Tosoh Bioscience, Inc

Diametra

DiaSorin S.p.A

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3120

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase